<?xml version='1.0' encoding='UTF-8'?>
<search_results><query id="7250">collagen vascular disease</query><engine status="OK" timestamp="2014-04-22 02:39:00" name="The Street" id="FW14-e108"/><snippets><snippet id="FW14-e108-7250-01"><link cache="FW14-topics-docs/e108/7250_01.html" timestamp="2014-04-22 02:39:01">http://www.thestreet.com/story/10329702/1/wednesdays-early-winners-losers.html</link><title>Wednesday's Early Winners &amp; Losers</title><description>Wednesday's Early Winners &amp; Losers

By Sarina Penn 06:51 AM EST 12/27/06

Vascular Solutions jumps after its hemostat product gains approval for a new use.

http://www.thestreet.com/story/10329702/1/wednesdays-early-winners-losers.html</description></snippet><snippet id="FW14-e108-7250-02"><link cache="FW14-topics-docs/e108/7250_02.html" timestamp="2014-04-22 02:40:15">http://www.thestreet.com/story/11230380/1/united-therapeutics-corporation-special-call.html</link><title>United Therapeutics Corporation Special Call</title><description>United Therapeutics Corporation Special Call

By Seeking Alpha 08:00 PM EDT 08/24/11

United Therapeutics Corporation Special Call

http://www.thestreet.com/story/11230380/1/united-therapeutics-corporation-special-call.html</description></snippet></snippets></search_results>